help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Page, G.
Right arrow Articles by Miossec, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Page, G.
Right arrow Articles by Miossec, P.
(American Journal of Pathology. 2004;164:409-417.)
© 2004 American Society for Investigative Pathology

Plasma Cell-Like Morphology of Th1-Cytokine-Producing Cells Associated with the Loss of CD3 Expression

Guillaume Page*, Arne Sattler{dagger}, Sabine Kersten{dagger}, Andreas Thiel{dagger}, Andreas Radbruch{dagger} and Pierre Miossec*

From INSERM U403 and the Departments of Immunology and Rheumatology,* Hôpital Edouard Herriot, Lyon, France; and the Deutsches Rheumaforschungszentrum Berlin,{dagger} Berlin, Germany

Here we clarified the morphology and phenotype of interleukin (IL)-17- and interferon (IFN)-{gamma}-producing cells in both in vitro and in vivo situations. Oligoclonal activation of normal peripheral blood mononuclear cells with the superantigen Staphylococcus aureus enterotoxin B and polyclonal activation with phorbol myristate acetate/phytohemagglutinin were used as in vitro models. This study was extended to various in vivo situations such as rheumatoid arthritis, dermatomyositis, and normal activated lymph nodes. The phenotype of IL-17- and IFN-{gamma}-producing cells was evaluated by immunohistochemistry using the CD3 and CD4 T-cell markers, the CD20, CD38, {kappa} and {lambda} light chain B-cell lineage markers. The expression of two chemokine receptors, CCR6 and CCR7, involved with their associated ligands CCL20 and CCL19/CCL21 in the migration of T lymphocytes, was evaluated in tissue sections. After both polyclonal and oligoclonal activation, IL-17+ and IFN-{gamma}+ cells acquired a plasma cell-like morphology associated with a high secretory activity, the reduced expression of CD3, and no change of CD4 expression. In rheumatoid arthritis, dermatomyositis, and activated lymph nodes, both IL-17- and IFN-{gamma}-producing cells had the same morphology. These Th1 cytokine-producing cells were CD4+-, CD3-, and B-cell lineage marker-negative. In both in vitro and in vivo situations, expression of CCR6 or CCR7 was not associated with a particular subset. In conclusion, activated T-helper CD4+ T cells, by their release of cytokines, seem to have functional similarities with plasma cells secreting immunoglobulins.





This article has been cited by other articles:


Home page
J. Immunol.Home page
S. P. Singh, H. H. Zhang, J. F. Foley, M. N. Hedrick, and J. M. Farber
Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6
J. Immunol., January 1, 2008; 180(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Zrioual, M.-L. Toh, A. Tournadre, Y. Zhou, M.-A. Cazalis, A. Pachot, V. Miossec, and P. Miossec
IL-17RA and IL-17RC Receptors Are Essential for IL-17A-Induced ELR+ CXC Chemokine Expression in Synoviocytes and Are Overexpressed in Rheumatoid Blood
J. Immunol., January 1, 2008; 180(1): 655 - 663.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Iwamoto, S.-i. Iwai, K. Tsujiyama, C. Kurahashi, K. Takeshita, M. Naoe, A. Masunaga, Y. Ogawa, K. Oguchi, and A. Miyazaki
TNF-{alpha} Drives Human CD14+ Monocytes to Differentiate into CD70+ Dendritic Cells Evoking Th1 and Th17 Responses
J. Immunol., August 1, 2007; 179(3): 1449 - 1457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society for Investigative Pathology.